Keryx Biopharmaceuticals, Inc.

Q1 2016 13F Holders

Symbol
KERX
CUSIP
492515101
Type
Equity
Class
COM
Num filings
148
Total reported value, excl. options
$315 M
Manager Report Date Value ($000) Shares Option Type